Ramanath Dukkipati is a Nephrology physician affiliated with University of California, Los Angeles. OpenAlex indexes 64 publications with 1,609 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
18546 Roscoe Blvd Ste 110
Northridge, CA 913244667
Telephone
818-993-5600Registry record last updated 17 Jul 2019.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202511 payments
- AKEBIA THERAPEUTICS INCProgram year20256 payments
- Amgen Inc.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55%Calcium channel blocker12.7%Amlodipine Besylate61%Nifedipine Er39%Part D≥28 patientsLoop diuretic10.7%Furosemide100%Part D≥46 patients+ 13 more classes in this area
Metabolism & gastrointestinal
16.2%SGLT2 inhibitor7.8%Farxiga80%Dapagliflozin10%Jardiance9%Part D<11 patientsProton pump inhibitor1.9%Pantoprazole Sodium58%Omeprazole42%Part D<11 patients+ 6 more classes in this area
Other
9.4%Drugs for treatment of hyperkalemia and hyperphosphatemia6.1%Lokelma69%Auryxia17%Velphoro14%Part D<11 patientsPhosphate Binder2.3%Sevelamer Carbonate100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evolution of continuous renal replacement therapy scenarios and the rise of anticoagulant-free continuous veno-venous hemodiafiltration
Current Opinion in Nephrology & Hypertension
2025 - Association of Prescribed Sodium Bicarbonate Therapy with All-Cause Mortality in a National Cohort of Veterans with Incident CKD
Journal of the American Society of Nephrology
2025 - Population health strategies for health equity in chronic kidney disease management
Current Opinion in Nephrology & Hypertension
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”